fluorodeoxyglucose f18 has been researched along with Giant Cell Arteritis in 222 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.45) | 18.2507 |
| 2000's | 42 (18.92) | 29.6817 |
| 2010's | 96 (43.24) | 24.3611 |
| 2020's | 83 (37.39) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, K; Arinobu, Y; Ayano, M; Horiuchi, T; Kimoto, Y; Kushimoto, K; Mitoma, H; Nakano, M; Niiro, H; Nishimura, K; Ono, N | 1 |
| Aide, N; Aouba, A; de Boysson, H; Prigent, K | 1 |
| Bijzet, J; Boots, AMH; Brouwer, E; de Jong, DM; Esen, I; Heeringa, P; Jiemy, WF; Nienhuis, PH; Slart, RHJA; van Sleen, Y | 1 |
| Barahona Z, D; Chong M, G; Cifuentes J, C; Schiappacasse F, G; Vicentela I, A | 1 |
| Dhaun, N; Pugh, D | 1 |
| Holzinger, J; Lakomek, HJ; Reinbold, WD; Witte, F | 1 |
| Aeschlimann, FA; Aquaro, GD; Grotenhuis, HB; Leiner, T; Raimondi, F; Saadoun, D | 1 |
| Akdemir, ÜÖ; Ataş, N; Atay, LÖ; Avanoglu Güler, A; Babaoglu, H; Bilici Salman, R; Göker, B; Gülbahar Ateş, S; Haznedaroğlu, Ş; Karadeniz, H; Koca, G; Küçük, H; Öztürk, MA; Paşaoğlu, H; Satış, H; Tufan, A; Yapar, D | 1 |
| Yildiz, H | 1 |
| Koster, MJ; Warrington, KJ | 1 |
| Fujihara, M; Koyama, T; Mizukawa, K; Nakatani, K; Sakata, E | 1 |
| Besutti, G; Boiardi, L; Casali, M; Galli, E; Giorgi Rossi, P; Mancuso, P; Marvisi, C; Muratore, F; Salvarani, C; Spaggiari, L; Versari, A | 1 |
| Al Khayyat, SG; Baldi, C; Bardelli, M; Cantarini, L; Conticini, E; D'Alessandro, R; Falsetti, P; Frediani, B; Gentileschi, S | 1 |
| Giraud, N; Prati, C; Verhoeven, F; Wendling, D | 1 |
| Besson, FL; Nocturne, G; Pean De Ponfilly-Sotier, M; Seror, R | 1 |
| Allegri, V; Fanti, S; Lanzafame, H; Mulè, R; Zanoni, L | 1 |
| Castañeda, S; González-Gay, MA; Prieto-Peña, D | 1 |
| Álvaro-Gracia, JM; Castrejón, I; González, C; López, K; Martínez-Barrio, J; Molina-Collada, J; Montero, F; Nieto-González, JC; Rivera, J; Trives, L | 1 |
| Kawamoto, M; Koizumi, N; Ohara, N; Takasugi, J | 1 |
| Ahlman, MA; Alessi, HD; Grayson, PC; Luo, Y; Novakovich, E; Quinn, KA; Saboury, B | 1 |
| Ahlman, MA; Alessi, HD; Grayson, PC; LaValley, MP; Marko, J; Neogi, T; Novakovich, E; Quinn, KA | 1 |
| Alberini, JL; Audia, S; Bejot, Y; Bonnotte, B; Cochet, A; Creuzot-Garcher, C; Devilliers, H; Drouet, C; Durand-Bailloud, B; Falvo, N; Greigert, H; Martin, L; Ramon, A; Samson, M; Soudry-Faure, A; Thibault, T | 1 |
| Freesmeyer, M; Gühne, F; Hoffmann, T; Malich, A; Malich, L; Oelzner, P; Pfeil, A; Weise, T; Wolf, G | 1 |
| Bley, TA; Buck, AK; Cousins, DS; Fröhlich, M; Guggenberger, KV; Higuchi, T; Isidro, U; Liao, JM; Navathe, AS; Rowe, SP; Schmalzing, M; Tony, HP; Vogt, ML; Wang, E; Werner, RA; Werner, RM; Zhu, J | 1 |
| Benali, K; Eshagh, D; Mageau, A; Papo, T; Sacre, K | 1 |
| Betrains, A; Blockmans, D; Moreel, L | 1 |
| Akiyama, M; Hama, S; Higashida-Konishi, M; Izumi, K; Okano, Y; Oshige, T; Oshima, H; Shimada, T | 1 |
| Collet, G; Demailly, F; Fagart, A; Quemeneur, T; Rousselin, C | 1 |
| Gopalan, D; Tarkin, JM | 1 |
| Benali, K; Casadepax-Soulet, C; Crestani, B; Dieudé, P; Ebstein, E; Forien, M; Juge, PA; Mahida, B; Ottaviani, S; Piekarski, E | 1 |
| Agard, C; Bénichou, A; Coudol, S; Espitia, O; Guédon, AF; Jamet, B; Karakachoff, M; Kraeber-Bodéré, F; Schanus, J; Serfaty, JM | 1 |
| Jayawickrama, W; Martin, J; Otome, O; Vijayaraghavan, N | 1 |
| Abe, Y; Ashizawa, K; Kawamata, N; Makiyama, A; Tamura, N | 1 |
| Osborne, MT; Tawakol, A | 1 |
| Asmar, A; Mark, PD; Skousen, MK | 1 |
| Agard, C; Alexandra, JF; Daumas, A; de Boysson, H; de Pinho, QG; Devauchelle-Pensec, V; Espitia, O; Genin, V; Granel, B; Héron, E; Jamet, B; Magnant, J; Martin, M; Quéméneur, T; Queyrel-Moranne, V; Rousselin, C; Sacre, K; Sailler, L; Samson, M; Serfaty, JM; Urbanski, G | 1 |
| Ludwig, DR; Morris, V; Vöö, S | 1 |
| Cortés-Romera, M; Estrada, P; Narváez, J; Nolla, JM; Sabaté-Llobera, A; Sánchez-Rodríguez, I; Vidal-Montal, P | 1 |
| Galli, E; Pipitone, N; Salvarani, C | 1 |
| Bui, C; Chen, J; Mansberg, R; Wong, VCK | 1 |
| Castañeda, S; González-Gay, MA; Heras-Recuero, E; Vicente-Rabaneda, EF | 1 |
| Bauckneht, M; Camellino, D; Cimmino, MA; Cutolo, M; Hysa, E; Iannuzzi, F; Morbelli, S; Sambuceti, G | 1 |
| Abele, J; Hans, V; Yacyshyn, E | 1 |
| Akarriou, M; Bacour, YAA; Comans, EFI; de Vet, HCW; Smit, F; Smulders, YM; van der Laken, CJ; van Kanten, MP; Voskuyl, AE | 1 |
| Betrains, A; Blockmans, D; Doumen, M; Molenberghs, G; Moreel, L; Vanderschueren, S | 1 |
| Forbess, LJ; Horomanski, A | 1 |
| Álvaro-Gracia, JM; Castrejón, I; de Miguel, E; Fernández-Fernández, E; Martínez-Barrio, J; Molina-Collada, J; Monjo-Henry, I; Torres Ortiz, G | 1 |
| Bond, M; Bosch, P; Dejaco, C; Falzon, L; Mackie, SL; Ponte, C; Ramiro, S; Schmidt, WA | 1 |
| Gabata, T; Inoue, D; Komori, T; Takamatsu, A; Taki, J; Watanabe, S; Yoshida, K | 1 |
| Betrains, A; Blockmans, D; Boeckxstaens, L; Claus, E; Coudyzer, W; Molenberghs, G; Moreel, L; Van Laere, K; Vanderschueren, S | 1 |
| Aschwanden, M; Berger, CT; Daikeler, T; Imfeld, S; Rottenburger, C; Schegk, E; Staub, D | 1 |
| Adedjouma, A; Buvat, I; Fain, O; Laurent, C; Mekinian, A; Ricard, L; Soussan, M | 1 |
| Bandini, V; Campochiaro, C; Tomelleri, A | 1 |
| Hartung, W; Schmidt, WA | 1 |
| Blockmans, D; Luqmani, R; Salvarani, C; Spaggiari, L | 1 |
| Ahlman, MA; Grayson, PC; Marko, J; Michailidou, D; Rimland, CA; Rosenblum, JS | 1 |
| Avanzi, GC; Bellan, M; Castello, L; Croce, A; Gavelli, F; Orsini, F; Pedrazzoli, R; Pirisi, M; Puta, E; Sacchetti, GM; Sainaghi, PP; Soddu, D; Sola, D; Zecca, E | 1 |
| Gormsen, LC; Hansen, IT; Hauge, EM; Keller, KK; Nielsen, BD; Therkildsen, P | 3 |
| Banzo, I; Blanco, R; Calderon-Goercke, M; Castañeda, S; González-Gay, MA; Martínez-Rodríguez, I; Prieto-Peña, D | 1 |
| Ahmadi Bidakhvidi, N; Blockmans, D; Gheysens, O; Goffin, K; Van Laere, K | 1 |
| Caterson, HC; Sammel, AM; Shah, PR; Wegner, EA | 1 |
| Bokhari, S; Fazlollahi, L; Nickerson, K; Perel-Winkler, A; Simon, R | 1 |
| Bailey, E; Brewer, J; Fraser, CL; Hsiao, E; Janssen, B; Laurent, R; Nguyen, K; Sammel, AM; Schembri, G; Schrieber, L; Youssef, P | 1 |
| Gormsen, LC; Nielsen, BD | 1 |
| Brouwer, E; Glaudemans, AWJM; Hop, H; Mulder, DJ; Sandovici, M; Slart, RHJA; van Roon, AM | 1 |
| Dasgupta, B; Kayani, A; Sebastian, A | 1 |
| Balázs, G; Dósa, E; Farkas, K; Járai, Z; Kolossváry, E; Moravszki, M | 1 |
| Nielsen, BD; Schmidt, WA | 1 |
| Jin, L; Schäfer, VS; Schmidt, WA | 1 |
| Aghayev, A; Bay, CP; Campia, U; DiCarli, M; Docken, WP; Gerhard-Herman, M; Mitchell, RN; Monach, PA; Steigner, ML; Tedeschi, S | 1 |
| Dasgupta, B; Sebastian, A; Tomelleri, A | 1 |
| Bonnefoy, PB; Goutte, J; Habouzit, V; Jacquet-Francillon, N; Prevot, N | 1 |
| Hoshi, T; Ieda, M; Sakai, S; Sato, A | 1 |
| Ahlman, MA; Dashora, H; Grayson, PC; Novakovich, E; Quinn, KA | 1 |
| Brouwer, E; Gheysens, O; Glaudemans, AWJM; Jamar, F; Slart, RHJA; Treglia, G; van der Geest, KSM | 1 |
| Ariyoshi, T; Kubo, M; Nawata, T; Okuda, S; Wada, Y; Yano, M | 1 |
| Ahangarani Farahani, Z; Ellingsen, T; Emamifar, A; Gerke, O; Hermann, AP; Hess, S; Jensen Hansen, IM; Syrak Hansen, P; Thye-Rønn, P | 1 |
| Bagnasco, M; Bauckneht, M; Camellino, D; Cimmino, MA; Cutolo, M; Morbelli, SD; Paparo, F; Pesce, G; Sambuceti, G | 1 |
| Karsten, E; Laurent, R; Little, CB; Nguyen, K; Sammel, AM; Smith, S; Xue, M | 1 |
| Cid, MC; Espígol-Frigolé, G; Grau, JM; Prieto-González, S | 1 |
| Aschwanden, M; Berger, C; Daikeler, T; Glatz, K; Imfeld, S; Mensch, N; Rottenburger, C; Staub, D | 1 |
| Keidar, Z; Massalha, S; Palchan Hazan, T | 1 |
| Ie, K; Kurosu, E; Matsuda, T; Motohashi, I; Okuse, C; Sakai, T; Yagihashi, K | 1 |
| Dobashi, H; Maeda, Y; Matsumoto, K; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y | 1 |
| Isernia, G; Silvestri, V | 1 |
| Aouba, A; Bienvenu, B; Boutemy, J; de Boysson, H; Dumont, A; Lambert, M; Liozon, E; Ly, KH; Maigné, G; Manrique, A; Martin Silva, N | 1 |
| Benck, U; Bergner, R; Hoffend, J; Krämer, BK; Löffler, C | 1 |
| Andersen, HR; Andreasen, RA; Bang, JC; Chrysidis, S; Emamifar, A; Farahani, ZA; Gerke, O; Gildberg-Mortensen, R; Hansen, IMJ; Hansen, PS; Hermann, AP; Hess, S; Laustrup, H; le Greves, S; Marcussen, N; Olsen, RN; Svendstrup, F; Thye-Rønn, P; Toftegaard, P | 1 |
| Marcolini, L; Martinelli, N | 1 |
| Aide, N; Aouba, A; Bienvenu, B; Boutemy, J; de Boysson, H; Dumont, A; Lambert, M; Liozon, E; Ly, KH; Maigné, G; Manrique, A; Martin Silva, N; Sultan, A | 1 |
| Aide, N; Aouba, A; Bienvenu, B; de Boysson, H; Huglo, D; Lambert, M; Liozon, E; Manrique, A; Monteil, J; Parienti, JJ | 1 |
| Blockmans, D; Muratore, F; Salvarani, C; Shoenfeld, Y; Soriano, A | 1 |
| Abad, S; Brillet, PY; Dhôte, R; Fain, O; Hommada, M; Larroche, C; Mekinian, A; Soussan, M | 1 |
| Bailey, DL; Bailey, E; Dunn, H; Farmakis, P; Fraser, CL; Hsiao, E; Janssen, B; Kuo, CH; Laurent, R; Nguyen, K; Roach, P; Sammel, AM; Schembri, G; Schrieber, L; Youssef, P | 1 |
| Pipitone, NAM; Salvarani, C; Versari, A | 1 |
| Aschwanden, M; Berger, CT; Daikeler, T; Imfeld, S; Juengling, F; Kyburz, D; Recher, M; Rottenburger, C; Schegk, E; Staub, D | 1 |
| Ahlman, MA; Alehashemi, S; Bagheri, AA; Bluemke, DA; Civelek, AC; Cupps, TR; Grayson, PC; Kaplan, MJ; Malayeri, AA; Merkel, PA; Novakovich, E | 1 |
| Blockmans, D | 3 |
| Hsiao, E; Laurent, R; Nguyen, K; Sammel, AM; Schembri, G | 1 |
| Besson, FL; Bley, TA; Blockmans, D; Brouwer, E; Cimmino, MA; Clark, E; Dasgupta, B; Dejaco, C; Diamantopoulos, AP; Direskeneli, H; Duftner, C; Iagnocco, A; Klink, T; Neill, L; Ponte, C; Ramiro, S; Salvarani, C; Schmidt, WA; Slart, RHJA; Whitlock, M | 1 |
| Amrane, S; Courtoy, C; de Worm, S; Gillet, E; Giot, JB; Huynen, P; Lepidi, H; Million, M; Moutschen, M; Prudent, E; Raoult, D; Van Esbroeck, M | 1 |
| Slart, RHJA | 1 |
| Ahlman, MA; Bagheri, AA; Civelek, AC; Grayson, PC; Malayeri, AA; Marko, J; Merkel, PA; Novakovich, E; Quinn, KA; Rosenblum, JS | 1 |
| Ayoub, T; Djama, D; Mohamed, R | 1 |
| Banzo, I; Blanco, R; Calderón-Goercke, M; Calvo-Río, V; Castañeda, S; Corrales, A; González-Gay, MÁ; González-Vela, C; Hernández, JL; Loricera, J; Martínez-Rodríguez, I; Prieto-Peña, D | 1 |
| Flaus, A; Gaultier, JB; Granjon, D; Habouzit, V; Prevot-Bitot, N | 1 |
| Bogsrud, TV; Ejlersen, JA; Gormsen, LC; Hansen, IT; Haraldsen, A; Hauge, EM; Hjorthaug, K; Keller, KK; Kramer, S; Nielsen, BD; Stolle, LB; Therkildsen, P | 1 |
| Aschwanden, M; Berger, CT; Daikeler, T; Rottenburger, C; Sommer, G; Staub, D | 1 |
| Chen, X; Fu, Z; Li, Q; Yang, X | 1 |
| Gupta, S; Jain, S | 1 |
| Mohamed, R | 1 |
| Bartenstein, P; Czihal, M; Dechant, C; Hoffmann, U; Ingenhoff, J; Proft, F; Rominger, A; Schramm, N; Schulze-Koops, H; Treitl, KM; Treitl, M | 1 |
| Akagi, T; Fujita, S; Morita, Y; Mukai, T | 1 |
| O'Mahony, D; Power, SP | 1 |
| Ahlman, MA; Banerjee, S; Civelek, AC; Grayson, PC; Gribbons, KB; Merkel, PA; Novakovich, E; Quinn, KA; Rosenblum, JS | 1 |
| Pelletier-Galarneau, M; Ruddy, TD | 1 |
| Besse, MC; Collercandy, N; Diot, E | 1 |
| Ben Bouallègue, F; Benkiran, M; Bourdon, A; De Verbizier, D; Hay, B; Mariano-Goulart, D; Vauchot, F | 1 |
| Abdalla, A; Ali, I; Molloy, E; Murphy, D | 1 |
| Camellino, D; Dejaco, C | 1 |
| Bley, T; Guggenberger, K | 1 |
| Sagar, AS; Sagar, D; Soussi, S | 1 |
| Basten, O; Decker, E; Librizzi, D; Müller-Ladner, U | 1 |
| Bartholomeusz, D; Crowhurst, T; Dobson, R; Hill, C; Lester, S; Nguyen, AD | 1 |
| Bauknecht, H; Buchert, R; Sobesky, J; Stengl, KL | 1 |
| Fojtík, Z; Křen, L; Rehák, Z; Staníček, J; Szturz, P | 1 |
| Hakman, P; Nowak, A; Vallelian, F | 1 |
| Bruls, S; Courtois, A; Defraigne, JO; Michel, JB; Namur, G; Nusgens, BV; Sakalihasan, N; Smeets, JP | 1 |
| Agostini, D; Besson, FL; Bienvenu, B; Bouvard, G; de Boysson, H; Parienti, JJ | 1 |
| Mihara, S; Oiwa, H; Sugiyama, E; Toko, M | 1 |
| Barbato, VA; Castro, R; Goertz, A | 1 |
| Alba, MA; Cid, MC; Corbera-Bellata, M; Depetris, M; Espígol-Frigolé, G; García-Martínez, A; Grau, JM; Hernández-Rodríguez, J; Lomeña, F; Planas-Rigol, E; Prieto-González, S; Tavera-Bahillo, I | 1 |
| Blagosklonov, O; Boulahdour, H; Prati, C; Wendling, D | 1 |
| Camellino, D; Cimmino, MA; Massollo, M; Paparo, F; Piccardo, A; Puppo, C; Rollandi, GA; Shoushtari Zadeh Naseri, M; Villavecchia, G | 1 |
| Blondet, C; Dietemann, S; Imperiale, A; Namer, IJ; Noblet, V | 1 |
| Bettenworth, D; Brückner, M; Heidemann, J; Hengst, K; Weckesser, M; Willeke, P | 1 |
| Bonnema, SJ; Larsen, CC; Schifter, S | 1 |
| Liu, Y; Tian, X; Wang, H; Zhang, W; Zhu, Z | 1 |
| Andrianasolo, M; Benyamine, A; Cammilleri, S; Daumas, A; Granel, B; Jean, E; Scafi, M | 1 |
| Brouwer, E; Comans, EF; Glaudemans, AW; Lensen, KD; Pereira Arias-Bouda, LM; Slart, RH; Smulders, YM; van der Laken, CJ; Voskuyl, AE; Zwijnenburg, AT | 1 |
| Ikusaka, M; Shikino, K; Shimada, F | 1 |
| Kornberg, MD; Probasco, JC; Ratchford, JN; Subramaniam, RM | 1 |
| Fain, O; Katsahian, S; Mekinian, A; Nicolas, P; Pop, G; Schramm, C; Soussan, M | 1 |
| Adam, J; Adam, Z; Bortlicek, Z; Fojtik, Z; Koukalova, R; Nemec, P; Rehak, Z; Rehakova, D; Vasina, J; Vavrusova, A | 1 |
| Caresia-Aróztegui, AP; Escudero, D; Lopez-Cancio Martínez, E; Mañé Martínez, MA; Martínez-Yélamos, S; Vidaller Palacín, A | 1 |
| Liu, TY; Miller, NR | 1 |
| Bernal Vidal, JA; Quilis, N; Vela, P | 1 |
| Arends, S; Brouwer, E; Glaudemans, AWJM; Lensen, KDF; Rutgers, A; Slart, RHJA; Stellingwerff, MD; van der Geest, KSM | 1 |
| Eiber, M; Einspieler, I; Thürmel, K | 1 |
| Ahlman, MA; Grayson, PC; Hughes, M; Malayeri, AA; Newman, KA; Pratt, D | 1 |
| Bucerius, J | 1 |
| Comans, EF; Lensen, KD; Smulders, YM; van der Laken, CJ; Voskuyl, AE | 1 |
| Aouba, A; Artigues, N; Bienvenu, B; Boutemy, J; de Boysson, H; Geffray, L; Hachulla, E; Hatron, PY; Huglo, D; Lambert, M; Liozon, E; Ly, K; Maigné, G; Manrique, A; Ollivier, Y; Parienti, JJ | 1 |
| Hanafusa, T; Komori, T; Kotani, T; Makino, S; Takeuchi, T; Wakura, D; Yoshida, S | 1 |
| Alexandra, JF; Benali, K; Chauchard, M; Coustet, B; Dieude, P; Dossier, A; Goulenok, T; Hyafil, F; Klein, I; Lariviere, D; Papo, T; Pasi, N; Sacre, K | 1 |
| Buttgereit, F; Dasgupta, B; Dejaco, C; Duftner, C; Matteson, EL | 1 |
| Ding, E; Jiang, W; Qin, L; Shen, J; Wei, X; Zhang, R | 1 |
| Ib Nielsen, H; Iyer, V; Vejlø, CS | 1 |
| Blockmans, D; Bobbaers, H; Coudyzer, W; De Ceuninck, L; Heye, S; Loeckx, D; Marchal, G; Stroobants, S; Vanderschueren, S | 1 |
| Hautzel, H; Heinzel, A; Müller, HW; Sander, O; Schneider, M | 1 |
| Hoffmann, U; Tatò, F | 2 |
| Hall, JK | 1 |
| Bley, T; Blockmans, D; Schmidt, W | 1 |
| Chu, J; Kok, J; Lin, M; Lin, P; Patapanian, H; Shingde, M | 1 |
| Ichikawa, Y; Itoh, G; Ozaki, S; Shibata, T | 1 |
| Heston, TF; Szabo, Z | 1 |
| Both, M; Gross, WL; Heller, M; Moosig, F; Nölle, B; von Forstner, C | 1 |
| Liozon, E; Ly, KH; Monteil, J; Vidal, E | 1 |
| Bogaard, K; Ezechiels, JP; Schrama, JG; Voogel, AJ; Zwijnenburg, A | 1 |
| Hrdina, C; Pfadenhauer, K; Weinerth, J | 1 |
| Akisaki, T; Hara, K; Kushida, S; Moriyama, H; Nagata, M; Sakurai, T; Taniguchi, M; Urakami, K; Yasuda, H; Yokono, K | 1 |
| Funauchi, M; Kinoshita, K; Kusunoki, S; Nakatani, K; Saito, Y; Samejima, K; Sioyama, M | 1 |
| Hayashi, H; Kasagi, S; Kawano, S; Kogata, Y; Kumagai, S; Misaki, K; Miura, N; Morinobu, A; Nakazawa, T; Nishimura, K; Saegusa, J; Sendo, S; Tsuji, G | 1 |
| Hashimoto, Y; Matsue, Y; Matsumura, A; Nagahori, W; Ohno, M; Suzuki, M | 1 |
| Agostini, D; Besson, FL; Bienvenu, B; Bouvard, G; Costo, S; Parienti, JJ; Prior, JO | 1 |
| Bartenstein, P; Czihal, M; Förster, S; Hacker, M; Hoffmann, U; Rominger, A; Tato, F; Weiss, M | 1 |
| Balink, H; Collins, J; Houtman, PM | 1 |
| Bajocchi, G; Boiardi, L; Casali, M; Formisano, D; Germanò, G; Magnani, L; Meliconi, R; Pipitone, N; Pulsatelli, L; Salvarani, C; Salvo, D; Versari, A | 1 |
| Dickinson, KK; McWilliams, ET; Raman, V; Walker, DM | 1 |
| Garza, I; Hunt, CH; Michet, CJ; Robertson, CE | 1 |
| Balink, H; Hooisma, GA; Houtman, PM; Lensen, KD; Slart, RH | 1 |
| Chaigne, B; Favelle, O; Magnant, J; Maillot, F; Rousselot, C | 1 |
| Fardet, L; Keller-Petrot, I; Pedinielli, A | 1 |
| Andersen, KF; Bülow, J; Skøt, J; Suetta, C | 1 |
| Jehanno, N; Maunoury, C; Thevenet, H; Weinmann, P | 1 |
| Baghaie, M; Beckers, C; Belhocine, T; Corman, V; Daenen, F; De Barsy, C; Delanaye, P; Demonty, J; Deprez, M; Foidart-Willems, J; Gomez, P; Hustinx, R; Kaye, O; Malaise, M; Rigo, P | 1 |
| Blockmans, DE | 1 |
| Belhocine, T; Blockmans, D; Hustinx, R; Mortelmans, L; Vandevivere, J | 1 |
| Dalhoff, K; Reincke, B; Rupp, J; Schaaf, B | 1 |
| Brodmann, M; Lipp, RW; Pabst, E; Passath, A; Pilger, E; Seinost, G | 1 |
| Aigner, R; Brodmann, M; Passath, A; Pilger, E; Seinost, G; Stark, G | 1 |
| Blockmans, D; Buysschaert, I; Knockaert, DC; Mortelmans, L; Vanderschueren, S | 1 |
| Bleeker-Rovers, CP; Bredie, SJ; Corstens, FH; Oyen, WJ; van der Meer, JW | 1 |
| Belhocine, T | 2 |
| De Simone, C; Famularo, G; Minisola, G | 1 |
| Brink, I; Vaith, P; Walker, UA; Weiner, SM | 1 |
| Espinola, D; Fletcher, TM | 1 |
| Bijl, M; de Leeuw, K; Jager, PL | 1 |
| Graf, M; Melzer, RA; Müller-Brand, J; Nitzsche, EU; Tyndall, A; Walter, MA | 1 |
| Melzer, RA; Müller-Brand, J; Nitzsche, EU; Schindler, C; Tyndall, A; Walter, MA | 1 |
| Bhatia, A; Edwards, JC; Ell, PJ | 1 |
| Pfadenhauer, K; Rüll, T | 1 |
| Blockmans, D; Bobbaers, H; de Ceuninck, L; Knockaert, D; Mortelmans, L; Vanderschueren, S | 1 |
| Garcia-Porrua, C; Gonzalez-Gay, MA; Miranda-Filloy, JA | 1 |
| Bolcák, K; Fojtík, Z; Frysáková, L; Rehák, Z; Stanícek, J | 1 |
| Cho, IH; Chun, KA; Hong, YH; Hyun, MS; Kim, MJ; Kim, YJ; Kwon, CM; Shin, DG | 1 |
| Bley, TA; Frydrychowicz, A; Langer, M; Markl, M; Uhl, M | 1 |
| Walter, MA | 1 |
| Earl-Graef, D; Reba, RC; Szmodis, ML | 1 |
| Ahmadi-Simab, K; Bähre, M; Both, M; Dourvos, O; Fritzer, E; Gross, WL; Heller, M; Reuter, M; Ullrich, S | 1 |
| Pipitone, N; Salvarani, C; Versari, A | 1 |
| de Paula, WD; Dos Anjos, DA; Dos Anjos, RF; Sobrinho, AB | 1 |
| Blockmans, D; Bobbaers, H; Bormans, G; Knockaert, D; Maes, A; Mortelmans, L; Nuyts, J; Stroobants, S | 1 |
| Blockmans, D; Maes, A; Mortelmans, L; Stroobants, S | 1 |
| Afschrift, M; De Winter, F; Dierckx, RA; Petrovic, M; Van de Wiele, C; Vogelaers, D | 1 |
| Goy, A; Larson, SM; Liebovitz, E; Macapinlac, H; Pui, J; Rusch, V; Turlakow, A; Yeung, HW | 1 |
41 review(s) available for fluorodeoxyglucose f18 and Giant Cell Arteritis
| Article | Year |
|---|---|
Overview of Imaging in Adult- and Childhood-onset Takayasu Arteritis.
Topics: Child; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Takayasu Arteritis; Tomography, X-Ray Computed; Young Adult | 2022 |
Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy.
Topics: Aged; Arthralgia; Drug-Related Side Effects and Adverse Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Pain; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography | 2023 |
Multimodality imaging of large-vessel vasculitis.
Topics: Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Takayasu Arteritis | 2023 |
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis.
Topics: Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Takayasu Arteritis | 2023 |
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Temporal Arteries | 2023 |
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Takayasu Arteritis | 2023 |
Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations.
Topics: Cross-Sectional Studies; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Prospective Studies | 2023 |
Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Positron-Emission Tomography; Takayasu Arteritis | 2019 |
Early large vessel systemic vasculitis in adults.
Topics: Adult; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Systemic Vasculitis | 2019 |
Myocarditis in Giant Cell Arteritis Diagnosed With Fluorine 18-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: Case Report and Review of the Literature.
Topics: Aged; Diagnosis, Differential; Dose-Response Relationship, Drug; Echocardiography; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stroke Volume; Treatment Outcome | 2020 |
18F-Fluorodeoxyglucose PET/Computed Tomography in the Diagnosis and Monitoring of Giant Cell Arteritis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Imaging in large-vessel vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Takayasu Arteritis | 2020 |
Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Takayasu Arteritis; Vasculitis | 2020 |
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Is PET/CT essential in the diagnosis and follow-up of temporal arteritis?
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2017 |
Usefulness of PET in recognizing and managing vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Research Design; Retroperitoneal Fibrosis; Sensitivity and Specificity; Vascular Diseases; Vasculitis | 2018 |
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.
Topics: Europe; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rheumatology; Takayasu Arteritis; Tomography, X-Ray Computed; Ultrasonography; Vasculitis | 2018 |
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Public Opinion | 2018 |
The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.
Topics: Aorta; Computed Tomography Angiography; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Temporal Arteries; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2018 |
PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Takayasu Arteritis; Vasculitis | 2019 |
Imaging in Large Vessel Vasculitides.
Topics: Arteries; Computed Tomography Angiography; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Positron-Emission Tomography; Sensitivity and Specificity; Takayasu Arteritis; Ultrasonography, Doppler, Duplex; Vasculitis | 2019 |
Case report and review of the literature: floating aortic thrombus.
Topics: Abdominal Pain; Aged; Aorta, Thoracic; Echocardiography, Transesophageal; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Predictive Value of Tests; Thrombosis; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2014 |
Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography.
Topics: Aorta, Thoracic; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiography; Vasculitis | 2014 |
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Hypermetabolism of Vertebral Arteries Revealing Giant Cell Arteritis.
Topics: Aged, 80 and over; Echocardiography, Transesophageal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron-Emission Tomography; Sensitivity and Specificity; Severity of Illness Index; Subclavian Artery; Tomography, X-Ray Computed; Vertebral Artery | 2015 |
Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2015 |
Monitoring Vasculitis with 18F-FDG PET.
Topics: Adult; Aged; Algorithms; Animals; Atherosclerosis; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Systemic Vasculitis; Takayasu Arteritis; Vasculitis; Whole Body Imaging | 2016 |
Extracranial giant cell arteritis: A narrative review.
Topics: Aortic Aneurysm; Aortic Arch Syndromes; Aortic Dissection; Aortitis; Axillary Artery; Biopsy; Carotid Artery Diseases; Computed Tomography Angiography; Femoral Artery; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Iliac Artery; Immunosuppressive Agents; Magnetic Resonance Angiography; Mesenteric Arteries; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Renal Artery; Subclavian Artery; Temporal Arteries; Vascular Surgical Procedures | 2016 |
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.
Topics: Aged; Cytokines; Dendritic Cells; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; T-Lymphocytes | 2017 |
Giant cell arteritis: a systemic vascular disease.
Topics: Angiography, Digital Subtraction; Arterial Occlusive Diseases; Biomarkers; Cardiovascular Agents; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Inflammation Mediators; Magnetic Resonance Angiography; Peripheral Vascular Diseases; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Color; Vascular Surgical Procedures | 2008 |
Giant-cell arteritis.
Topics: Aspirin; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Interleukin-6; Magnetic Resonance Angiography; Methotrexate; Platelet Count; Radiopharmaceuticals; Ultrasonography, Doppler, Color | 2008 |
Imaging for large-vessel vasculitis.
Topics: Aorta; Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Predictive Value of Tests; Ultrasonography; Vasculitis | 2009 |
[Imaging techniques in the evaluation of primary large vessel vasculitides: Part 2: duplex ultrasound, positron emission tomography, computed tomography, and ophthalmological methods].
Topics: Angiography; Aortic Aneurysm; Aortic Dissection; Arterial Occlusive Diseases; Cone-Beam Computed Tomography; Diagnostic Techniques, Ophthalmological; Emergencies; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Optic Neuropathy, Ischemic; Positron-Emission Tomography; Retinal Artery Occlusion; Sensitivity and Specificity; Takayasu Arteritis; Tomography, X-Ray Computed; Ultrasonography, Doppler, Duplex | 2009 |
Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography | 2011 |
PET in vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Takayasu Arteritis; Vasculitis | 2011 |
Diagnosis and extension of giant cell arteritis. Contribution of imaging techniques.
Topics: Cerebral Angiography; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data.
Topics: Arteries; Arteriosclerosis; Arteritis; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Takayasu Arteritis; Tomography, Emission-Computed; Vasculitis | 2003 |
Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Rituximab | 2005 |
Giant cell arteritis: diagnosis and therapeutic management.
Topics: Biopsy; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Arteries; Ultrasonography, Doppler | 2006 |
[MRI in giant cell (temporal) arteritis].
Topics: Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Temporal Arteries; Ultrasonography, Doppler, Color | 2007 |
[(18)F]fluorodeoxyglucose PET in large vessel vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Tomography, X-Ray Computed | 2007 |
Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Positron-Emission Tomography; Takayasu Arteritis; Tomography, X-Ray Computed; Ultrasonography, Doppler; Vasculitis | 2008 |
9 trial(s) available for fluorodeoxyglucose f18 and Giant Cell Arteritis
| Article | Year |
|---|---|
PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritis.
Topics: Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Temporal Arteries | 2023 |
Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Topics: Biopsy; Denmark; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Neoplasms; Osteoporosis; Patient Selection; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisolone; Prevalence; Radiopharmaceuticals; Single-Blind Method; Steroids; Temporal Arteries; Vasculitis | 2017 |
Topics: Adult; Aged; Arteries; Biomarkers; Cohort Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Takayasu Arteritis | 2018 |
Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2018 |
[Disease activity assessment in large vessel vasculitis].
Topics: Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Interleukin-6; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Interleukin-6; Sensitivity and Specificity; Severity of Illness Index; Takayasu Arteritis | 2011 |
Detection of alterations in brain glucose metabolism by positron emission tomography in Takayasu's arteritis.
Topics: Adolescent; Adult; Arteries; Arteriosclerosis; Arteritis; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucose; Humans; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Takayasu Arteritis; Tomography, Emission-Computed; Vasculitis | 2004 |
The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Takayasu Arteritis | 2005 |
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methylprednisolone; Polymyalgia Rheumatica; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Risk; Shoulder Joint; Treatment Outcome | 2006 |
New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.
Topics: Aged; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Radiopharmaceuticals; Subclavian Artery; Tomography, Emission-Computed | 1999 |
172 other study(ies) available for fluorodeoxyglucose f18 and Giant Cell Arteritis
| Article | Year |
|---|---|
HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
Topics: Aged; Alleles; Fluorodeoxyglucose F18; Giant Cell Arteritis; HLA-B52 Antigen; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
JAK Inhibitor Effectiveness in Giant-Cell Arteritis With Large-Vessel Involvement Assessed by 18F-FDG PET-CT.
Topics: Aged; Arteritis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Janus Kinase Inhibitors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2022 |
Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.
Topics: Biomarkers; Carrier Proteins; Chitinase-3-Like Protein 1; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Leukocyte L1 Antigen Complex; Membrane Proteins; Positron Emission Tomography Computed Tomography; Pyruvate Kinase; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
[Positron emission tomography-CT scan (PET-CT) in the diagnosis of large vessel vasculitis].
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis; Tomography, X-Ray Computed | 2021 |
Comment on: A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG PET/CT: a Chinese cohort study.
Topics: China; Cohort Studies; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2022 |
[Polymyalgia rheumatica in 18-fluorodeoxyglucose-positron-emission-tomography/computed tomography : Improvement in diagnostic accuracy and differentiation from rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Electrons; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Interleukin-6; Male; Middle Aged; Positron-Emission Tomography; Takayasu Arteritis | 2022 |
Giant Cell Arteritis: The Place of
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Haptoglobins; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
In Reply-Giant Cell Arteritis: The Place of
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Haptoglobins; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Systemic Vasculitis Following SARS-CoV-2 mRNA Vaccination Demonstrated on FDG PET/CT.
Topics: Aged, 80 and over; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; mRNA Vaccines; Positron Emission Tomography Computed Tomography; RNA, Messenger; SARS-CoV-2; Systemic Vasculitis; Vaccination; Vaccines, Synthetic | 2022 |
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Takayasu Arteritis | 2022 |
Polymyalgia Rheumatica: A syndrome with an enthesitic subset? Comment on: "Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice" by Marie Pean de Ponfilly-Sotier et al. Joint Bone Spine 2021;89:10
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Spondylarthritis | 2022 |
On the use of
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Spondylarthritis | 2022 |
Answer to Giraud et al. "On the use of 18F FDG PET-CT in spondyloarthritis." Joint Bone Spine 2022;89:105377 and to Falsetti et al. "Polymyalgia Rheumatica: a syndrome with an enthesitic subset?" Joint Bone Spine 2022;89:105378.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Spondylarthritis; Syndrome | 2022 |
A Peculiar 18 F-FDG Spinal Uptake Helps Diagnosis and Effective Treatment of Polymyalgia Rheumatica : "The Corset Sign".
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography | 2022 |
The role of PET/CT in the evaluation of patients with large-vessel vasculitis: useful for diagnosis but with potential limitations for follow-up.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vasculitis | 2022 |
The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis.
Topics: Aged; Arteries; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
FDG-PET/CT of Giant Cell Arteritis with Normal Inflammatory Markers.
Topics: Biomarkers; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single-Center Prospective Study.
Topics: Disease Progression; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Prospective Studies; Takayasu Arteritis | 2023 |
Association of
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Takayasu Arteritis | 2023 |
Distribution patterns of arterial affection and the influence of glucocorticoids on
Topics: Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2022 |
Topics: Accountable Care Organizations; Aftercare; Aged; C-Reactive Protein; Cohort Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Leukocyte Count; Medicare; Patient Discharge; Positron Emission Tomography Computed Tomography; United States | 2021 |
Persistent FDG uptake in large vessels and risk of relapse in giant cell arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2022 |
PET/CT in giant cell arteritis: will the best imaging technique please stand up?
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
A "Leopard Man" Aspect on 18 F-FDG PET/CT Revealing a VEXAS Syndrome.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Mutation; Polychondritis, Relapsing; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Semi-Quantitative [
Topics: Aortitis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2022 |
Atypical giant cell arteritis presentations diagnosed with FDG-18 whole body PET imaging.
Topics: Aged; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisolone | 2023 |
PET/CT Reveals Localized Inflammation in the Temporal, Vertebral, and Lower Extremity Arteries in Giant Cell Arteritis.
Topics: Aged, 80 and over; Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Lower Extremity; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Somatostatin Receptor 2-Targeted PET Radiotracers Shine in Assessing Inflammatory Activity in Large Vessel Vasculitis.
Topics: Arteritis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Receptors, Somatostatin; Takayasu Arteritis | 2023 |
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis.
Topics: Aged; Aortitis; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2023 |
Fast-track pathway for early diagnosis and management of giant cell arteritis: the combined role of vascular ultrasonography and [18F]-fluorodeoxyglucose PET-computed tomography imaging.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Methylprednisolone; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
FDG PET/CT Imaging of Severe Polymyalgia Rheumatica.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis?
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica | 2023 |
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Incidental findings on FDG-PET/CT in large vessel vasculitis.
Topics: Aged; Alberta; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Vasculitis | 2023 |
Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis.
Topics: Arteritis; Atherosclerosis; Cell Differentiation; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2023 |
Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis: comparative study with FDG-PET/CT.
Topics: Aortitis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Ultrasonography | 2023 |
Comparison of 18 F-FDG PET Findings of Pegfilgrastim-Induced Aortitis With Other Types of Large-Vessel Vasculitis : A Retrospective Observational Study.
Topics: Aorta, Abdominal; Aortitis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Immunoglobulin G; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2023 |
Association Between Vascular
Topics: Cohort Studies; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Prospective Studies | 2023 |
[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?
Topics: Aged; Aged, 80 and over; Aorta; Axillary Artery; Carotid Artery, Common; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Popliteal Artery; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Subclavian Artery; Temporal Arteries; Ultrasonography; Vertebral Artery | 2020 |
PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrosis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Takayasu Arteritis; Young Adult | 2019 |
Bilateral temporal arteries 18F-FDG PET uptake in giant cell arteritis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Temporal Arteries | 2020 |
[Imaging diagnostics in large vessel vasculitis].
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis; Tomography, X-Ray Computed | 2019 |
Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis.
Topics: Adult; Aged; Carotid Arteries; Carotid Artery Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Headache; Humans; Intermittent Claudication; Magnetic Resonance Angiography; Male; Middle Aged; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Symptom Assessment; Takayasu Arteritis | 2020 |
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis.
Topics: Aged; Aortitis; Cost of Illness; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Temporal Arteries; Ultrasonography | 2020 |
18F-FDG PET in Giant Cell Arteritis.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Ophthalmic Inflammation on Positron Emission Tomography in Vision-Threatening Giant Cell Arteritis.
Topics: Aged; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Medical Illustration; Positron-Emission Tomography; Radiopharmaceuticals; Retinal Artery; Vision Disorders | 2020 |
Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; New South Wales; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Time Factors; Treatment Outcome | 2020 |
Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis.
Topics: Aged; Aged, 80 and over; Axillary Artery; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Temporal Arteries; Ultrasonography, Doppler, Color | 2020 |
Excellent Response to Leflunomide in a Case of Large-Vessel Giant Cell Arteritis Demonstrated Simultaneously by Clinical, Laboratory, Ultrasound, and Positron Emission Tomography/Computed Tomography Parameters.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Laboratories; Leflunomide; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2021 |
The potentials and importance of imaging in large-vessel vasculitis
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Takayasu Arteritis | 2020 |
Clinically isolated aortitis: imaging features and clinical outcomes: comparison with giant cell arteritis and giant cell aortitis.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Aortic Aneurysm; Aortitis; Aortography; Computed Tomography Angiography; Diagnosis, Differential; Dilatation, Pathologic; Disease Progression; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
Comment on: Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Comment on: Diagnostic accuracy of ultrasound for detecting large vessel giant cell arteritis using FDG PET/CT as the reference: reply.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT.
Topics: Abdomen; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
In vivo evaluation of coronary arteritis by serial optical coherence tomography in large vessel vasculitis.
Topics: Arteritis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Takayasu Arteritis; Tomography, Optical Coherence | 2021 |
Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Brain; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Positron-Emission Tomography | 2021 |
Images in Vascular Medicine: Usefulness of carotid ultrasonography for diagnosis and management of polymyalgia rheumatica-associated large-vessel vasculitis.
Topics: Cardiology; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Ultrasonography | 2021 |
Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
Topics: Adipose Tissue, White; Age Factors; Aged; Aged, 80 and over; Aorta; Biopsy; Blood Pressure; Body Composition; Bone Density; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Longitudinal Studies; Male; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisolone; Prognosis; Pulse Wave Analysis; Sex Factors; Temporal Arteries; Vascular Stiffness | 2021 |
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Limited utility of novel serological biomarkers in patients newly suspected of having giant cell arteritis.
Topics: Adrenal Cortex Hormones; Aged; Biomarkers; Biopsy; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Interferon-gamma; Interleukin-12; Interleukin-6; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Procalcitonin; Sensitivity and Specificity; Serum Amyloid P-Component; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2021 |
An 80-year-old man with headache, orbital pain and elevated ESR: challenges in the diagnosis of a patient with suspected giant cell arteritis.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Temporal Arteries; Tomography, X-Ray Computed | 2021 |
18F-FDG PET/CT compared with ultrasound and biopsy for detection of vasculitis of the temporal artery branches.
Topics: Biopsy; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Temporal Arteries | 2021 |
[18F-FDG-PET/CT AS A TOOL FOR DIAGNOSIS AND FOLLOW-UP OF INFLAMMATORY DISEASES OF LARGE BLOOD VESSELS].
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
A Long-term Persistent Vascular Fluorodeoxyglucose Uptake in a Patient with Large-vessel Vasculitis.
Topics: Aorta; Arteritis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Combination of whole body [
Topics: Angiography; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Suspected Giant Cell Aortitis: From Multiple Aortic Structural Damage to Fatal Listeria Sepsis, a Case Report.
Topics: Aged; Aortic Aneurysm, Thoracic; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Computed Tomography Angiography; Contrast Media; Fatal Outcome; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Listeriosis; Multiple Organ Failure; Positron-Emission Tomography; Prosthesis-Related Infections; Sepsis; Whole Body Imaging | 2017 |
Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
Topics: Aged; Aged, 80 and over; Aorta; Carotid Arteries; Comorbidity; Female; Femoral Artery; Fluorodeoxyglucose F18; Follow-Up Studies; France; Giant Cell Arteritis; Glucocorticoids; Humans; Iliac Artery; Male; Middle Aged; Multicenter Studies as Topic; Outcome and Process Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies | 2017 |
The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Leukocyte Count; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Temporal Arteries; Ultrasonography, Doppler, Color | 2017 |
Without Headache: Fever of Unknown Cause Due to Giant Cell Arteritis.
Topics: Aged; Aorta; Biopsy; Diagnosis, Differential; Female; Fever; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Arteries | 2018 |
Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement.
Topics: Aged; Aged, 80 and over; Aorta; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2017 |
Repetitive
Topics: Aged; Female; Fluorodeoxyglucose F18; France; Giant Cell Arteritis; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
Aortitis in giant cell arteritis: diagnosis with FDG PET/CT and agreement with CT angiography.
Topics: Adult; Aged; Aged, 80 and over; Aortitis; Case-Control Studies; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Fluorine-18 Fluoro-2-Deoxyglucose Positron Emission Tomography Uptake in the Superficial Temporal and Vertebral Arteries in Biopsy Positive Giant Cell Arteritis.
Topics: Aged; Diagnostic Techniques, Ophthalmological; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Temporal Arteries; Vertebral Artery; Vision Disorders | 2017 |
[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.
Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Biopsy, Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Hospitals, University; Humans; Immunohistochemistry; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; Switzerland; Time Factors; Visual Acuity | 2018 |
Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Maxillary artery 18F-FDG uptake as a new finding on PET/CT scan in a cohort of 41 patients suspected of having giant cell arteritis.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Maxillary Artery; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2018 |
A case of giant cell arteritis associated with culture-proven Coxiella burnetii aortitis.
Topics: Aged; Anti-Bacterial Agents; Aorta, Abdominal; Aortitis; Coxiella burnetii; Doxycycline; Fluorodeoxyglucose F18; Giant Cell Arteritis; Heart Valve Prosthesis Implantation; Humans; Hydroxychloroquine; Male; Positron Emission Tomography Computed Tomography; Q Fever; Treatment Outcome | 2018 |
Comparison of magnetic resonance angiography and
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Takayasu Arteritis; Young Adult | 2018 |
Diagnostic positron emission tomography-computed tomography in clinically elusive giant cell arteritis.
Topics: Aged; Aorta, Thoracic; Brain Ischemia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Predictors of positive
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography | 2019 |
Unusual and Diffuse Hypermetabolism in Routine 18F-FDG PET/CT of the Supra-aortic Vessels in Biopsy-Positive Giant Cell Arteritis.
Topics: Aged; Aorta; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study.
Topics: Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Occult Giant Cell Arteritis Concurrent With Pancreatic Carcinoma Revealed by 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Incidental Findings; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Comment on: Diagnostic positron emission tomography-computed tomography in clinically elusive giant cell arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Response to comment on: Diagnostic positron emission tomography-computed tomography in clinically elusive giant cell arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Diagnostic accuracy of positron emission tomography for assessment of disease activity in large vessel vasculitis.
Topics: Aorta; Biomarkers; Databases, Factual; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Observer Variation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Takayasu Arteritis | 2019 |
Complete resolution of giant cell arteritis after tocilizumab monotherapy determined by positron emission tomography-CT.
Topics: Aged; Antibodies, Monoclonal, Humanized; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Headache; Humans; Induction Chemotherapy; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Diffuse large vessel giant cell arteritis found by
Topics: Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Nausea; Positron Emission Tomography Computed Tomography; Prednisolone; Weight Loss | 2019 |
Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis.
Topics: Adult; Aged; Antirheumatic Agents; Biological Products; Blood Sedimentation; C-Reactive Protein; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Takayasu Arteritis; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Young Adult | 2020 |
Gynecologic Vasculitis: Positron Emission Tomography-Computed Tomography Contribution in a Rare Localization of Giant Cell Arteritis.
Topics: Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography | 2019 |
Diagnostic performance of
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Temporal Arteries | 2019 |
Connecting the dots: a story of unknown fever, acute coronary syndrome and pan-aortitis-an occult relapse of a large vessel vasculitis.
Topics: Acute Coronary Syndrome; Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging | 2019 |
Should
Topics: Cross-Sectional Studies; Double-Blind Method; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies | 2019 |
Chronic Cough in a 70-Year-Old Woman.
Topics: Aged; Anti-Inflammatory Agents; Aorta; C-Reactive Protein; Cough; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Oximetry; Positron Emission Tomography Computed Tomography; Prednisolone; Radiopharmaceuticals; Respiratory Function Tests; Thorax; Treatment Outcome | 2019 |
[Hand ischemia and increased CRP level in a 75-year-old female patient].
Topics: Aged; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Ischemia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Severity of Illness Index; South Australia; Takayasu Arteritis | 2019 |
A hidden giant: Wallenberg syndrome and aortal wall thickening as an atypical presentation of a giant cell arteritis.
Topics: Aged; Biopsy; Diagnosis, Differential; Echocardiography, Transesophageal; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Lateral Medullary Syndrome; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Steroids; Stroke; Tomography, X-Ray Computed | 2013 |
Upsampling from aorta and aortic branches: PET/CT hybrid imaging identified 18F-FDG hypermetabolism in inflamed temporal and occipital arteries.
Topics: Aorta; Aortography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Occipital Lobe; Positron-Emission Tomography; Temporal Lobe; Tomography, X-Ray Computed | 2014 |
[Giant cell arteritis].
Topics: Adrenal Cortex Hormones; Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prednisone; Prognosis; Risk Factors; Temporal Arteries; Ultrasonography, Doppler | 2013 |
Increased metabolic activity highlighted by positron emission tomography/computed tomography in the wall of the dissected ascending aorta in a patient with Horton disease.
Topics: Aged; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortography; Blood Vessel Prosthesis Implantation; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study.
Topics: Aged; Case-Control Studies; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Biopsy of the temporal artery in a patient with giant cell arteritis.
Topics: Aged, 80 and over; Biopsy; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Arteries; Vertebral Artery | 2013 |
Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study.
Topics: Acute-Phase Proteins; Aged; Aged, 80 and over; Aorta; Area Under Curve; Arteries; Axillary Artery; Biopsy; Carotid Arteries; Case-Control Studies; Female; Femoral Artery; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Iliac Artery; Interleukin-6; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Subclavian Artery; Temporal Arteries; Tomography, X-Ray Computed | 2014 |
Positron emission tomography: the ideal tool in polymyalgia rheumatica?
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Neoplasms; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
FDG PET findings of the brain in sudden blindness caused by bilateral central retinal artery occlusion revealing giant cell arteritis.
Topics: Aged; Blindness; Brain; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retinal Artery Occlusion; Tomography, X-Ray Computed | 2015 |
Giant cell arteritis exclusively detected by 18F-fluorodeoxyglucose positron emission tomography: a case report.
Topics: Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
[Giant cell arteritis diagnosed by PET-CT scan].
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron Emission Tomography Computed Tomography; Prednisolone; Radiopharmaceuticals | 2014 |
[The value of (18)F-FDG PET/CT in diagnosing giant cell arteritis presenting as fever of unknown origin].
Topics: Aged; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Middle Aged; Physical Examination; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.
Topics: Aged; Arteries; Atherosclerosis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2015 |
FDG positron emission tomography of giant cell arteritis with polymyalgia rheumatica.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Giant cell arteritis mimicking infiltrative leptomeningeal disease of the optic nerves.
Topics: Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Meningeal Carcinomatosis; Methylprednisolone; Optic Nerve; Positron-Emission Tomography; Temporal Arteries; Vision Disorders | 2015 |
Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Bursitis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Multimodal Imaging; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Synovitis; Vasculitis | 2015 |
Positron emission tomography/computed tomography with 18-fluorodeoxyglucose: A technique for assessing vasculitis of the central nervous system secondary to giant cell arteritis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Nervous System; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Giant Cell Arteritis Presenting as Unilateral Anterior Ischemic Optic Neuropathy Associated With Bilateral Optic Nerve Sheath Enhancement on Magnetic Resonance Imaging.
Topics: Aged; Blood Sedimentation; C-Reactive Protein; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Myelin Sheath; Optic Nerve; Optic Nerve Diseases; Positron-Emission Tomography | 2015 |
F-18 DG PET/CT ear chondritis image in a patient with giant cell arteritis.
Topics: Aged; Cartilage Diseases; Ear Cartilage; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron-Emission Tomography; Research Design; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Fully integrated whole-body [18F]-fludeoxyglucose positron emission tomography/magnetic resonance imaging in therapy monitoring of giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Angiography; Male; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
Topics: Aftercare; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Asymptomatic Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Fractures, Spontaneous; Giant Cell Arteritis; Humans; Humeral Fractures; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Subclavian Steal Syndrome; Temporal Arteries; Vincristine | 2016 |
18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients.
Topics: Aged; Aged, 80 and over; Aortic Diseases; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Rheumatology; ROC Curve | 2016 |
Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Giant Cell Arteritis Incidentally Detected by Positron Emission Tomography-Computed Tomography in a Patient With Atypical Symptoms.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Arteries; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Methylprednisolone; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2017 |
[Picture of the month: giant cell arteritis].
Topics: Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Aorta; Aorta, Abdominal; Aorta, Thoracic; Aortography; Dilatation, Pathologic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Risk Factors; Sex Factors; Tomography, X-Ray Computed | 2008 |
Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio.
Topics: Aged; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Liver; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2008 |
[18F]FDG PET/CT in the diagnosis of large vessel vasculitis.
Topics: Aged; Aorta; Aortitis; Blood Vessel Prosthesis Implantation; Coronary Artery Bypass; Fatal Outcome; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Postoperative Complications; Prednisone; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
[A case of polymyalgia rheumatica where a complication of large-vessel vasculitis was diagnosed by FDG-PET].
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Positron-Emission Tomography | 2009 |
Giant cell arteritis on 18F-FDG PET/CT.
Topics: Aortitis; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Incidental Findings; Kidney Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
[Vasculitis assessment with [18F]FDG positron emission tomography].
Topics: Aortitis; Arteritis; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Vasculitis | 2010 |
Images in cardiovascular medicine: Detection of giant cell aortitis using 18F-fluorodeoxyglucose positron emission tomography computed tomography.
Topics: Aorta; Aortography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Vertebral arteries: a target for FDG-PET imaging in giant cell arteritis? Clinical, ultrasonographic and PET study in 46 patients.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography; Vertebral Artery | 2011 |
Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of asymptomatic giant cell arteritis in a patient with Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
[Case of temporal arteritis: FDP-PET ((18)F-fluorodeoxyglucose-positron emission tomography) was useful for early diagnosis and treatment].
Topics: Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Positron-Emission Tomography | 2010 |
Role of imaging studies in the diagnosis and evaluation of giant cell arteritis in Japanese: report of eight cases.
Topics: Aged; Aged, 80 and over; Aortitis; Carotid Arteries; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Japan; Positron-Emission Tomography; Retrospective Studies; Temporal Arteries; Ultrasonography, Doppler, Color | 2011 |
A case of giant cell arteritis with massive pericardial effusion.
Topics: Aged; Echocardiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methylprednisolone; Multimodal Imaging; Pericardial Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Extremities; Female; Fluorodeoxyglucose F18; Germany; Giant Cell Arteritis; Humans; Male; Middle Aged; Physical Examination; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Ultrasonography, Doppler, Color | 2011 |
18F-FDG PET versus PET/CT as a diagnostic procedure for clinical suspicion of large vessel vasculitis.
Topics: Arteritis; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Takayasu Arteritis | 2011 |
Acute inflammatory aortitis: utility of hybrid imaging with positron emission tomography/computed tomography in diagnosis and follow-up.
Topics: Acute Disease; Aortitis; Azathioprine; Biopsy; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
(18)F-FDG PET/CT may be useful when evaluating a patient for giant cell arteritis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study.
Topics: Aged; Early Diagnosis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2012 |
18 FDG PET/CT contribution in occult giant-cell arteritis.
Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Asthenia; Biopsy; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Weight Loss | 2012 |
[A case of giant cell arteritis [correction of arthritis] diagnosed with 18FDG-positron emission tomography].
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography | 2012 |
[Large vessel vasculitis diagnosed by positron emission tomography/computed tomography presenting with non-specific symptoms].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2012 |
[Increased uptake on PET/CT].
Topics: Aged; Aorta, Thoracic; Aortic Aneurysm; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
[Horton's disease and extra-temporal vessel locations: role of 18FDG PET scan. Report of 3 cases and review of the literature].
Topics: Aged; Aorta; Carotid Arteries; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucose; Humans; Male; Middle Aged; Radiopharmaceuticals; Subclavian Artery; Tomography, Emission-Computed | 2002 |
Polymyalgia rheumatica and giant-cell arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Polymyalgia Rheumatica; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[PET-imaging proves giant-cell arteritis as the cause of FUO in a patient with a pulmonary nodule of unknown malignancy].
Topics: Aged; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Radiopharmaceuticals; Temporal Arteries; Tomography, Emission-Computed; Ultrasonography, Doppler, Duplex | 2004 |
F18-FDG-PET as a helpful tool in the diagnosis of giant cell arteritis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Comment on Meller et al.: Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis.
Topics: Aged; Aorta; Aorta, Thoracic; Arteries; Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Takayasu Arteritis; Temporal Arteries; Tomography, Emission-Computed; Ultrasonography | 2004 |
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
Topics: Aged; Aortitis; Blood Glucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Polyarteritis Nodosa; Prednisone; Sensitivity and Specificity; Tomography, Emission-Computed; Vasculitis | 2004 |
The right place of 18FDG PET for the diagnosis of giant cell arteritis--a response to the article of Brodmann et al.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Fluorodeoxyglucose positron emission tomography for the diagnosis of giant cell arteritis.
Topics: Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET.
Topics: Adolescent; Adult; Arteries; Arteriosclerosis; Arteritis; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucose; Humans; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Takayasu Arteritis; Tomography, Emission-Computed; Vasculitis | 2004 |
Positron emission tomography in the diagnosis of giant cell arteritis.
Topics: Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Methylprednisolone; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals | 2004 |
Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Positron-Emission Tomography; Prednisolone; Prognosis; Takayasu Arteritis; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[18F]FDG-PET of giant-cell aortitis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2005 |
Ultrasonographic and FDG-PET imaging in active giant cell arteritis of the carotid arteries.
Topics: Aged; Carotid Arteries; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Enhancement; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Ultrasonography | 2005 |
Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases.
Topics: Aged; Angiography, Digital Subtraction; Blood Sedimentation; C-Reactive Protein; Female; Femoral Artery; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Popliteal Artery; Positron-Emission Tomography; Radiopharmaceuticals; Tibial Arteries; Ultrasonography, Doppler, Duplex | 2006 |
[18F-FDG PET in the diagnosis of large vessel vasculitis].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis; Vasculitis | 2006 |
A case of silent giant cell arteritis involving the entire aorta, carotid artery and brachial artery screened by integrated PET/CT.
Topics: Aorta; Biopsy; Blood Sedimentation; Brachial Artery; Carotid Arteries; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Positron-Emission Tomography; Temporal Arteries; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Positron emission tomography in the diagnosis and management of giant cell arteritis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron-Emission Tomography | 2007 |
MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis.
Topics: Aged; Aged, 80 and over; Aortic Arch Syndromes; Aortitis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
F-18 FDG PET/CT in giant cell arteritis with polymyalgia rheumatica.
Topics: Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Polymyalgia Rheumatica; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch.
Topics: Aged; Aortitis; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Radiopharmaceuticals; Subclavian Artery; Tomography, Emission-Computed | 2000 |
Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Middle Aged; Radiopharmaceuticals; Splenic Diseases; Thoracic Arteries; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis.
Topics: Aged; Anemia, Hypochromic; Anti-Inflammatory Agents; Biopsy; Blood Sedimentation; Fatigue; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Headache; Humans; Prednisolone; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Weight Loss | 2001 |